Literature DB >> 24389491

Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses.

Kimie Sai1, Kouichi Kurose, Tomoko Koizumi, Noriko Katori, Jun-ichi Sawada, Yasuhiro Matsumura, Nagahiro Saijo, Noboru Yamamoto, Tomohide Tamura, Haruhiro Okuda, Yoshiro Saito.   

Abstract

Human orosomucoid (ORM) is a major acute-phase plasma protein, encoded by 2 highly homologous genes, ORM1 and ORM2. Human ORM induction is assumed to be regulated by each proximal promoter region, where putative glucocorticoid responsive elements and CCAAT/enhancer binding protein (C/EBP)β binding sites are located. However, the details of the differential regulation of these genes remain unknown. To explore this, we assessed the role of the distal promoter region of each ORM in HeLa cells. Luciferase-reporter activities of full constructs, containing approximately 1.1 kbp (FULL), and those of deletion constructs, containing up to 188 bp region (DEL) upstream of the transcription start sites of ORM1 and ORM2 were compared under both basal and inducer-treated conditions. For ORM1 and ORM2 DEL constructs, significantly increased activities after dexamethasone (DEX) treatments (alone and combined with interleukin (IL)-1β) were observed. Significantly higher FULL construct activities than DEL construct activities were observed for ORM1 after IL-1β treatment, while those for ORM2 were significantly lower at basal level and after DEX treatments. Upon C/EBPβ overexpression, FULL construct activities were significantly higher than those of DEL constructs at basal level and after IL-1β treatment for ORM1, and at basal level and after inducer-treatments for ORM2. Higher transcription-induction activity in the distal promoter region was evident for ORM1 in the absence of C/EBPβ overexpression, and for ORM2 under C/EBPβ overexpression conditions. These findings suggest that the ORM distal promoter region differentially regulates expression of ORM genes at basal level and in acute phase responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24389491     DOI: 10.1248/bpb.b13-00551

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  [LC-MS/MS-based screening of new protein biomarkers for cervical precancerous lesions and cervical cancer].

Authors:  Feng Qiu; Fu Chen; Dongdong Liu; Jianhua Xu; Jingling He; Jujiao Xiao; Longbin Cao; Xianzhang Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

2.  Ozone-induced acute phase response in lung versus liver: the role of adrenal-derived stress hormones.

Authors:  Devin I Alewel; Andres R Henriquez; Catherine H Colonna; Samantha J Snow; Mette C Schladweiler; Colette N Miller; Urmila P Kodavanti
Journal:  J Toxicol Environ Health A       Date:  2020-12-14

3.  Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.

Authors:  Tao Fang; Meiling Cui; Ji Sun; Chao Ge; Fangyu Zhao; Lin Zhang; Hua Tian; Lixing Zhang; Taoyang Chen; Guoping Jiang; Haiyang Xie; Ying Cui; Ming Yao; Hong Li; Jinjun Li
Journal:  Oncotarget       Date:  2015-06-30

4.  Characterization of mammalian Lipocalin UTRs in silico: Predictions for their role in post-transcriptional regulation.

Authors:  Andres Mejias; Sergio Diez-Hermano; Maria D Ganfornina; Gabriel Gutierrez; Diego Sanchez
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

5.  Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting.

Authors:  Chad N Brocker; Donghwan Kim; Tisha Melia; Kritika Karri; Thomas J Velenosi; Shogo Takahashi; Daisuke Aibara; Jessica A Bonzo; Moshe Levi; David J Waxman; Frank J Gonzalez
Journal:  Nat Commun       Date:  2020-11-17       Impact factor: 14.919

6.  Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk.

Authors:  Sonia Lopez; Angel Martinez-Perez; Alba Rodriguez-Rius; Ana Viñuela; Andrew A Brown; Laura Martin-Fernandez; Noelia Vilalta; Marc Arús; Nikolaos I Panousis; Alfonso Buil; Maria Sabater-Lleal; Juan Carlos Souto; Emmanouil T Dermitzakis; Jose Manuel Soria
Journal:  Thromb Haemost       Date:  2022-03-10       Impact factor: 6.681

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.